Results 161 to 170 of about 21,869 (297)
Novel Antihypertensive Medications to Target the Renin-Angiotensin System: Mechanisms and Research. [PDF]
Jiang Z, Zhai C, Tang G.
europepmc +1 more source
Physiologic responses to water immersion in man: A compendium of research [PDF]
A total of 221 reports published through December 1973 in the area of physiologic responses to water immersion in man were summarized. The author's abstract or summary was used whenever possible.
Dorchak, K. J.+3 more
core +1 more source
Reframing the role of glucagon‐like peptide 1 receptor agonists in cardiovascular medicine
ESC Heart Failure, Volume 12, Issue 2, Page 923-926, April 2025.
Riccardo M. Inciardi+3 more
wiley +1 more source
Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi+9 more
wiley +1 more source
Abstract Aims Despite the high risk of rehospitalization for heart failure (HF) and death among patients admitted to the intensive cardiac care unit (ICCU), no accurate prediction score for these outcomes exists. We aimed to develop a risk score to predict unplanned HF hospitalization and death 1‐year post‐discharge in an unselected cohort of patients ...
Andreas Bugge Tinggaard+116 more
wiley +1 more source
Effectiveness of Acetazolamide in Patients With Heart Failure: A Systematic Review and Meta-Analysis. [PDF]
Eda S+7 more
europepmc +1 more source
ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease [PDF]
Adams LG+19 more
core +1 more source
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh+18 more
wiley +1 more source
Sacubitril/valsartan preserves regional cardiac function following myocardial infarction in rats
Parts of the figure were drawn by using pictures from Servier Medical Art. Servier Medical Art by Servier is licensed under a Creative Commons Attribution 3.0 Unported License (https://creativecommons.org/licenses/by/3.0/). Abstract Aims Sacubitril/valsartan (Sac/Val) is used for treatment of heart failure. The effect of Sac/Val on regional dysfunction
Einar Sjaastad Nordén+16 more
wiley +1 more source
Subcutaneous furosemide in heart failure: a systematic review. [PDF]
Osmanska J+5 more
europepmc +1 more source